NASDAQ: PMGMPriveterra Acquisition Corp Stock
$10.38+0.01 (+0.1%)
Updated May 26, 2023
PMGM Price
$10.38
Fair Value Price
$2,470.82
Market Cap
$92.41M
52 Week Low
$9.77
52 Week High
$10.55
P/E
129.75x
P/B
-12.63x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$3.21M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.09
Operating Cash Flow
-$1M
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PMGM Overview
Priveterra Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the medical technology sector. The company was incorporated in 2020 and is based in Fort Lauderdale, Florida.
Zen Score
–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PMGM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PMGM ($10.38) is undervalued by 99.58% relative to our estimate of its Fair Value price of $2,470.82 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PMGM ($10.38) is significantly undervalued by 99.58% relative to our estimate of its Fair Value price of $2,470.82 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PMGM was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PMGM due diligence checks available for Premium users.
Be the first to know about important PMGM news, forecast changes, insider trades & much more!
PMGM News
Valuation
PMGM fair value
Fair Value of PMGM stock based on Discounted Cash Flow (DCF)
Price
$10.38
Fair Value
$2,470.82
Undervalued by
99.58%
PMGM ($10.38) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PMGM ($10.38) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PMGM was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PMGM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
129.75x
Industry
41.44x
Market
54.23x
PMGM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PMGM is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PMGM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-12.63x
Industry
-27.13x
PMGM's financial health
Profit margin
Revenue
$0.0
Net Income
-$388.5k
Profit Margin
0%
PMGM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$21.6M
Liabilities
$7.9M
Debt to equity
-1.09
PMGM's short-term liabilities ($5.87M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PMGM's long-term liabilities ($2.07M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PMGM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PMGM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$623.9k
Investing
$260.0M
Financing
-$259.0M
PMGM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PMGM vs Shell Company Stocks
Priveterra Acquisition Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.